| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2008 | Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C virus infection: a follow-up study in Taiwan | Chen, CL; Yang, HI; Yang, WS; Liu, CJ; Chen, PJ; You, SL; Wang, LY; Sun, CA; Lu, SN; Chen, DS; Chen, CJ | Gastroenterology 135,111-121 | | | |
| 2004 | Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers. | Chang, KW; Lee, TC; Yeh, WI; Chung, MY; Liu, CJ; Chi, LY; Lin, SC | British journal of cancer 91(8), 1551-5 | | | |
| 2019 | Taiwan consensus statement on the management of chronic hepatitis B. | Chien, RN; Kao, JH; Peng, CY; Chen, CH; Liu, CJ; Huang, YH; Hu, TH; Yang, HI ; Lu, SN; Ni, YH; Chuang, WL; Lee, CM; Wu, JC; Chen, PJ; Liaw, YF | JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 118(1 Pt 1), 7-38 | | | |
| 2016 | Targeting cancer initiating cells by promoting cell differentiation and restoring chemosensitivity via dual inactivation of STAT3 and src activity using an active component of antrodia cinnamomea mycelia. | Chang, CW; Chen, YS; Chen, CC; Chan, IO; Chen, CC; Sheu, SJ; Lin, TW; Chou, SH; Liu, CJ; Lee, TC; Lo, JF | Oncotarget 7(45), 73016-73031 | | | |
| 2008 | Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma | Chou, YC; Yu, MW; Wu, CF; Yang, SY; Lin, CL; Liu, CJ; Shih, WL; Chen, PJ; Liaw, YF; Chen, CJ | Gut 57, 91-97 | | | |
| 2011 | X-ray synthesized PEGylated (polyethylene glycol coated) gold nanoparticles in mice strongly accumulate in tumors | Wang, CH; Liu, CJ; Chien, CC; Chen, HT; Hua, TE; Leng, WH; Chen, HH; Kempson, IM; Hwu, YK; Hsiao, M; Lai, TC; Wang, JL; Yang, CS; Lin, HM; Chen, YJ; Margaritondo, G | Mater Chem Phys 126(1-2), 352-356. Cited 6 | | | |
